Darryl Glubrecht

1.7k total citations
35 papers, 1.3k citations indexed

About

Darryl Glubrecht is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Darryl Glubrecht has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Cell Biology. Recurrent topics in Darryl Glubrecht's work include Peroxisome Proliferator-Activated Receptors (7 papers), Retinal Development and Disorders (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Darryl Glubrecht is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Retinal Development and Disorders (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Darryl Glubrecht collaborates with scholars based in Canada, United States and France. Darryl Glubrecht's co-authors include Roseline Godbout, John R. Mackey, Raymond Lai, Rong‐Zong Liu, Laith Dabbagh, Charles Dumontet, Carol E. Cass, Randeep Sangha, James Young and Jennifer L. Spratlin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Darryl Glubrecht

34 papers receiving 1.3k citations

Peers

Darryl Glubrecht
Jennifer M. Atkinson United States
John Lahad United States
Richard E. Cutler United States
Timothy G. Pestell United States
Joanne R. Doherty United States
Gabriela Schneider United States
Bin Gui China
Darryl Glubrecht
Citations per year, relative to Darryl Glubrecht Darryl Glubrecht (= 1×) peers Federica Maione

Countries citing papers authored by Darryl Glubrecht

Since Specialization
Citations

This map shows the geographic impact of Darryl Glubrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl Glubrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl Glubrecht more than expected).

Fields of papers citing papers by Darryl Glubrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl Glubrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl Glubrecht. The network helps show where Darryl Glubrecht may publish in the future.

Co-authorship network of co-authors of Darryl Glubrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl Glubrecht. A scholar is included among the top collaborators of Darryl Glubrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl Glubrecht. Darryl Glubrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirschenman, Raven, Namrata Patel, Joy Wang, et al.. (2025). Multiple anti-tumor programs are activated by blocking BAD phosphorylation. Oncogene. 44(29). 2530–2546.
2.
Choi, Wonshik, et al.. (2023). Abstract 1736: Role of brain fatty acid binding protein in glioblastoma microtube formation. Cancer Research. 83(7_Supplement). 1736–1736. 1 indexed citations
3.
Santos, Sofia Nascimento dos, Melinda Wuest, Jennifer Dufour, et al.. (2023). Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO. Nuclear Medicine and Biology. 124-125. 108383–108383. 6 indexed citations
4.
Wuest, Melinda, Justin J. Bailey, Jennifer Dufour, et al.. (2022). Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases. EJNMMI Research. 12(1). 46–46. 2 indexed citations
5.
Mackey, John R., Erwan Beauchamp, Weifeng Dong, et al.. (2021). N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target. Breast Cancer Research and Treatment. 186(1). 79–87. 18 indexed citations
6.
Glubrecht, Darryl, et al.. (2020). PET Imaging of l-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (xc−) with [18F]FDOPA and [18F]FSPG in Breast Cancer Models. Molecular Imaging and Biology. 22(6). 1562–1571. 5 indexed citations
7.
Hildebrandt, Matthew R., Yixiong Wang, Lei Li, et al.. (2019). Cytoplasmic aggregation of DDX1 in developing embryos: Early embryonic lethality associated with Ddx1 knockout. Developmental Biology. 455(2). 420–433. 14 indexed citations
8.
Jain, Saket, Darryl Glubrecht, Devon R. Germain, Markus Moser, & Roseline Godbout. (2018). AP-2ε Expression in Developing Retina: Contributing to the Molecular Diversity of Amacrine Cells. Scientific Reports. 8(1). 3386–3386. 6 indexed citations
9.
Tietz, Ole, Melinda Wuest, Darryl Glubrecht, et al.. (2016). PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model. EJNMMI Research. 6(1). 37–37. 29 indexed citations
10.
Li, Xiaodong, Frédéric Gaillard, Elizabeth A. Monckton, et al.. (2016). Loss of AP-2delta reduces retinal ganglion cell numbers and axonal projections to the superior colliculus. Molecular Brain. 9(1). 62–62. 10 indexed citations
11.
Liu, Rong‐Zong, et al.. (2015). CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid. Molecular Cancer. 14(1). 129–129. 56 indexed citations
12.
Sharma, Sai Kiran, Melinda Wuest, Monica Wang, et al.. (2014). Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging. EJNMMI Research. 4(1). 60–60. 24 indexed citations
13.
Liu, Rong‐Zong, Kathryn Graham, Darryl Glubrecht, et al.. (2012). A fatty acid‐binding protein 7/RXRβ pathway enhances survival and proliferation in triple‐negative breast cancer. The Journal of Pathology. 228(3). 310–321. 54 indexed citations
14.
Katyal, Sachin, Darryl Glubrecht, Lei Li, Zhihua Gao, & Roseline Godbout. (2011). Disabled-1 Alternative Splicing in Human Fetal Retina and Neural Tumors. PLoS ONE. 6(12). e28579–e28579. 15 indexed citations
15.
Liu, Rong‐Zong, Kathryn Graham, Darryl Glubrecht, et al.. (2011). Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer. American Journal Of Pathology. 178(3). 997–1008. 128 indexed citations
16.
Germain, Devon R., Kathryn Graham, Darryl Glubrecht, et al.. (2010). DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Research and Treatment. 127(1). 53–63. 56 indexed citations
17.
Glubrecht, Darryl, Jong Hyuk Kim, Laurie Russell, J. Bamforth, & Roseline Godbout. (2009). Differential CRX and OTX2 expression in human retina and retinoblastoma. Journal of Neurochemistry. 111(1). 250–263. 53 indexed citations
18.
Monckton, Elizabeth A., et al.. (2009). Nuclear Factor I Regulates Brain Fatty Acid-Binding Protein and Glial Fibrillary Acidic Protein Gene Expression in Malignant Glioma Cell Lines. Journal of Molecular Biology. 391(2). 282–300. 52 indexed citations
19.
Li, Xiaodong, et al.. (2008). Expression of AP‐2δ in the developing chick retina. Developmental Dynamics. 237(11). 3210–3221. 12 indexed citations
20.
Katyal, Sachin, Zhihua Gao, Elizabeth A. Monckton, Darryl Glubrecht, & Roseline Godbout. (2007). Hierarchical Disabled-1 Tyrosine Phosphorylation in Src family Kinase Activation and Neurite Formation. Journal of Molecular Biology. 368(2). 349–364. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026